Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer
暂无分享,去创建一个
André Toulouse | Josée Hébert | Raouf Fetni | J. Hébert | A. Toulouse | Jane J Pappas | Raouf Fetni | W E C Bradley | W. Bradley | J. Pappas
[1] J. den Hertog,et al. Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness. , 1991, DNA sequence : the journal of DNA sequencing and mapping.
[2] J. Knoll,et al. Allele specificity of DNA replication timing in the Angelman/Prader–Willi syndrome imprinted chromosomal region , 1994, Nature Genetics.
[3] J. Trasler. Origin and roles of genomic methylation patterns in male germ cells. , 1998, Seminars in cell & developmental biology.
[4] J. Minna,et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.
[5] B. Houle,et al. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Bird,et al. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein. , 1992, The EMBO journal.
[7] R. Momparler,et al. Quantitation of inhibition of DNA methylation of the retinoic acid receptor beta gene by 5-Aza-2'-deoxycytidine in tumor cells using a single-nucleotide primer extension assay. , 2000, Analytical biochemistry.
[8] A. Chess,et al. Asynchronous replication and allelic exclusion in the immune system , 2001, Nature.
[9] H. Tsou,et al. Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .
[10] C. Clarke,et al. Expression and regulation of retinoic acid receptors in human breast cancer cells. , 1992, Cancer research.
[11] A. Feinberg,et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.
[12] M. Fackler,et al. DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.
[13] P. Jones,et al. The DNA methylation paradox. , 1999, Trends in genetics : TIG.
[14] Alexander Dobrovic,et al. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. , 2002, Carcinogenesis.
[15] D. Sugarbaker,et al. High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.
[16] C. Croce,et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. , 2003, Cancer research.
[17] V. Seewaldt,et al. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. , 1997, Experimental cell research.
[18] B. Houle,et al. Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines. , 1994, Cancer research.
[19] A. Chess,et al. Coordination of the random asynchronous replication of autosomal loci , 2003, Nature Genetics.
[20] A. Chess. Monoallelic expression of protocadherin genes , 2005, Nature Genetics.
[21] M. Tsao,et al. Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. , 1994, Experimental cell research.
[22] P. Chambon,et al. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. , 1991, Experimental cell research.
[23] J. Minna,et al. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[24] J. Minna,et al. DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.
[25] R. Pili,et al. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. , 2002, Cancer research.
[26] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[27] A. Chess,et al. Monoallelic Expression and Asynchronous Replication of p120 Catenin in Mouse and Human Cells* , 2005, Journal of Biological Chemistry.
[28] B. Neel,et al. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer , 1995, Molecular and cellular biology.
[29] I. Simon,et al. Allelic inactivation regulates olfactory receptor gene expression , 1994, Cell.
[30] M. Widschwendter,et al. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. , 1997, Cancer research.
[31] D. Sinnett,et al. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. , 1999, Anti-cancer drugs.
[32] R. Momparler,et al. Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells , 2001, Cancer Chemotherapy and Pharmacology.
[33] C. Carpenter,et al. DNA methylation analysis: a powerful new tool for lung cancer diagnosis , 2002, Oncogene.
[34] C. Glass,et al. Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.
[35] S. Sukumar,et al. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.
[36] Y. Bang,et al. Methylation of specific CpG sites in the promoter region could significantly down‐regulate p16INK4a expression in gastric adenocarcinoma , 2000, International journal of cancer.
[37] M. Mansukhani,et al. Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.
[38] M. Surani,et al. Imprinting and the Epigenetic Asymmetry Between Parental Genomes , 2001, Science.
[39] A. Bird,et al. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.
[40] M. Basik,et al. Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalance. , 2003, Cancer research.
[41] J. Minna,et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. , 2001, Cancer research.
[42] D. Higgs,et al. The pattern of replication at a human telomeric region (16p13.3): its relationship to chromosome structure and gene expression. , 1999, Human molecular genetics.
[43] M. Ehrlich,et al. The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.
[44] A. Dobrovic,et al. erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma. , 1988, Cancer research.
[45] G. Deng,et al. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer , 2002, British Journal of Cancer.
[46] S. Clark,et al. High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.
[47] A. Dobrovic,et al. A frequent HindIII RFLP on chromosome 3p21-25 detected by a genomic erbA beta sequence. , 1988, Nucleic acids research.
[48] D. Sinnett,et al. Demethylation by 5-aza-2´-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ß gene in human colon carcinoma cells , 1998, Anti-cancer drugs.
[49] Christopher B Umbricht,et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR , 2001, The Lancet.
[50] M. Widschwendter,et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.
[51] Y. Kuppumbatti,et al. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells , 2000, Oncogene.
[52] A. Friedl,et al. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. , 2000, Cancer research.
[53] R. Momparler,et al. Activation of the retinoic acid receptor β gene by 5-aza-2’-deoxycytidine in human DLD-1 colon carcinoma cells , 1997, Anti-cancer drugs.
[54] B. Houle,et al. Implication of RARB in Epidermoid (Squamous) Lung Cancer , 1991, Genes, chromosomes & cancer.
[55] J. Herman,et al. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. , 1999, Blood.
[56] J. Minna,et al. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer , 1987, Nature.
[57] S. Hirohashi,et al. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. , 2002, Nucleic acids research.